01Principles and purposeThe professional or clinical skill and the decisions it supports.
Pituitary or suprasellar surgery can injure hypothalamic AVP-producing neurons, the stalk or posterior-pituitary storage system. Loss of AVP prevents renal concentration, producing large volumes of dilute urine. If thirst and access to water are intact, sodium may remain normal; if either fails, free-water deficit and hypernatraemia can evolve quickly.
Postoperative polyuria has many mimics. Excretion of intraoperative fluid, hyperglycaemia, mannitol, diuretics and recovery from cortisol deficiency can all increase urine output. Diagnosis therefore pairs volume and urine dilution with serum sodium or osmolality and symptoms. Water deprivation testing is inappropriate in an acutely postoperative, potentially unstable patient.
The early course may be transient, permanent, biphasic or triphasic. Initial AVP deficiency can be followed several days later by release of stored hormone and water retention, then by recurrent permanent deficiency. Desmopressin that was appropriate during the first phase can worsen hyponatraemia during the second, so each dose is a new clinical decision.
Key points
- Postoperative AVP deficiency is suspected when hypotonic polyuria is accompanied by thirst or rising plasma tonicity; urine volume alone is non-specific after surgery.
- A published pituitary-surgery proposal defines polyuria as more than 300 mL/hour for three consecutive hours with urine specific gravity below 1.005, plus thirst, serum osmolality above 300 mOsm/kg or sodium above 145 mmol/L.
- Exclude perioperative fluid mobilisation, hyperglycaemia, diuretics, mannitol, renal dysfunction and other solute diuresis before attributing every high urine output to AVP deficiency.
- If thirst is intact and water is accessible, allow drinking to thirst and replace only additional deficit; patients unable to drink need supervised fluid replacement and closer monitoring.
- Use desmopressin for confirmed, clinically important ongoing water loss that cannot be safely matched, then wait for dilute polyuria to recur before redosing in the early postoperative phase.
- Reassess urine output and sodium before every dose because transient AVP deficiency can resolve or enter an SIADH-like antidiuretic phase several days after surgery.
- Discharge only with stable sodium and fluid balance, clear desmopressin instructions, planned sodium review and warning signs for both recurrent polyuria and water-retaining hyponatraemia.
02Situations and prioritiesThe context, relevant information and actions that matter most.
Large sustained urine volumes with low specific gravity or osmolality are the key renal phenotype, but must be interpreted against fluid and solute exposure.
Increasing sodium or serum osmolality supports net free-water loss and strengthens the diagnosis when urine remains inappropriately dilute.
Intense thirst and drinking can maintain sodium despite AVP deficiency; absent thirst or inaccessible water markedly increases danger.
Sudden reduction in urine output, weight gain or falling sodium after earlier polyuria suggests recovery, desmopressin excess or a triphasic antidiuretic phase.
Cortisol deficiency can reduce free-water clearance and mask polyuria; replacement may reveal AVP deficiency as urine output increases.
03Assessment and interpretationHow to gather information, assess the situation and recognise uncertainty.
Consider the information, its meaning and its limitations before deciding what follows.
- 01
Hourly urine output and fluid balance - Why
- Confirm sustained polyuria, quantify free-water loss and identify sudden phase transitions.
- Interpretation and limitations
- More than 300 mL/hour for three hours is one proposed adult postoperative threshold; weight-based and local thresholds are needed for smaller adults and children.
- 02
Urine specific gravity or osmolality - Why
- Show whether urine is appropriately concentrated for the circulating tonicity.
- Interpretation and limitations
- Specific gravity below 1.005 or very low urine osmolality supports hypotonic polyuria, while concentrated urine suggests a solute or different mechanism.
- 03
Serial serum sodium and osmolality - Why
- Measure the consequence of water loss and guide replacement and desmopressin decisions.
- Interpretation and limitations
- A rising trend, sodium above 145 mmol/L or osmolality above 300 mOsm/kg supports AVP-deficient water loss in the proposed diagnostic scheme.
- 04
Glucose, renal function and medication review - Why
- Exclude glycosuria, osmotic therapy, diuretics and impaired renal concentrating capacity.
- Interpretation and limitations
- A competing cause may fully or partly explain polyuria; mixed mechanisms require treatment of each contributor rather than reflex desmopressin.
- 05
Paired response after prescribed desmopressin - Why
- Assess whether urine concentrates and losses fall after a clinically indicated dose.
- Interpretation and limitations
- A concentrating response supports AVP deficiency, but treatment response is monitored for water retention and is not a substitute for the initial differential.
04Worked approachesCases with ordered reasoning, an action and a check of the outcome.
01Worked caseEarly dilute polyuria after surgeryEight hours after transsphenoidal surgery, an adult passes 400 mL/hour for four hours, urine specific gravity is 1.003 and sodium rises from 140 to 147 mmol/L with marked thirst.+
- 1Context: verify intake and output, haemodynamics and access to water; repeat sodium, serum and urine osmolality, glucose and renal function, and review intraoperative fluids, mannitol, diuretics and glucocorticoids.
- 2Reasoning: sustained hypotonic polyuria plus thirst and rising sodium meets the proposed postoperative AVP-deficiency pattern after competing solute diuresis has been assessed.
- 3Outcome: allow drinking to thirst if safe, replace any additional deficit, involve endocrinology, and give cautious desmopressin if losses cannot be matched or hypernatraemia continues.
- 4Verification: check urine output and sodium frequently, withhold automatic redosing until dilute polyuria recurs, and watch over subsequent days for falling output and sodium.
02DiagnosisPolyuria assessment sequenceUrine output rises unexpectedly after pituitary or suprasellar surgery.+
- 1Confirm sustained output and obtain urine specific gravity or osmolality with simultaneous sodium, serum osmolality and glucose.
- 2Assess thirst, drinking ability, volume status, intraoperative fluid, mannitol, diuretics, glycosuria, renal function and glucocorticoid timing.
- 3Diagnose AVP deficiency only when hypotonic polyuria is physiologically inappropriate for plasma tonicity and the clinical context supports it.
03Desmopressin safetyDose and phase reassessmentConfirmed AVP-deficient losses cannot be safely replaced by drinking and supervised fluid alone.+
- 1Use the smallest route-appropriate prescribed dose under the specialist protocol, recognising that intranasal absorption can be unreliable soon after transsphenoidal surgery.
- 2Follow urine output, sodium, intake and weight; permit a planned period of aquaresis before repeat dosing when clinically safe.
- 3Withhold and seek urgent review if output falls unexpectedly, sodium declines or symptoms of water intoxication appear.
05Feedback, follow-up and evidenceReview outcomes, seek feedback and identify what to improve.
- Record hourly urine output during the unstable phase and pair every interpretation with intake, thirst, fluid prescriptions, sodium and recent desmopressin.
- Check sodium at least every four hours during active fluid resuscitation in a significantly unwell patient, increasing frequency when correction is rapid or unstable.
- Measure weight and assess volume status because falling weight supports net water loss whereas weight gain can expose antidiuresis or over-replacement.
- Before each desmopressin dose, confirm recurrence of dilute polyuria and review sodium; do not redose solely because a clock time has arrived.
- After discharge, arrange early endocrine contact and sodium surveillance, and later reassess whether AVP deficiency persists before declaring lifelong treatment.
06Special situationsVariants, exceptions and circumstances that change the usual approach.
Normal sodium can coexist
A thirsty patient with free access to water may compensate for large dilute losses, so normal sodium does not exclude AVP deficiency.
Polyuria is a phenotype
The diagnosis requires inappropriate urine dilution for the patient’s tonicity; fluid mobilisation and solute diuresis can produce similar volumes.
Each dose is provisional
Early postoperative desmopressin treats the current phase, while recovery or stored AVP release can remove the indication within hours.
Steroids can unmask loss
Correcting cortisol deficiency restores free-water clearance and may reveal previously hidden AVP-deficient polyuria and rising sodium.
Thirst determines safety
Assessment must include cognition, mobility, swallowing and water access because intact renal loss becomes dangerous when replacement cannot occur.
07Common pitfallsFrequent interpretation and management errors.
- 01
Diagnosing AVP deficiency from one high urine-output hour without urine dilution, tonicity change or review of intraoperative fluids.
- 02
Restricting water in a patient with active AVP-deficient losses and intact thirst, thereby accelerating hypernatraemia.
- 03
Giving scheduled desmopressin through a falling-output antidiuretic phase and causing dilutional hyponatraemia.
- 04
Using intranasal medication immediately after nasal surgery without recognising unpredictable absorption and the specialist route plan.
- 05
Calling the condition permanent at discharge without later reassessment after the transient postoperative period.